Objectives In a prospective phase IV trial of the first-line oral treatment dimethyl fumarate (DMF), we examined dynamics of neurofilament light (NFL) chain in serum, plasma and cerebrospinal fluid ...

Only one paper has previously described dimethyl fumarate (DMF) transfer during breastfeeding in two patients at 5 and 6 months postpartum, respectively. The current case report describes maternal ...

Mark Cuban is best known for business and basketball, but lately his passion has been shaking up the pharmaceutical world by ...

Dimethyl fumarate (Tecfidera) is an oral capsule you take twice daily. The exact mechanism of this drug is unknown. It appears to work by interfering with the activity of certain immune system ...

The decision means that Vumerity (diroximel fumarate) – a follow-up to Biogen's older oral therapy Tecfidera (dimethyl fumarate) – is now available to eligible patients across the UK ...

Tecfidera (dimethyl fumarate) is approved to treat relapsing forms of MS in adults. Tecfidera is believed to have anti-inflammatory and antioxidant properties that help protect against damage to the ...

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acschembio.4c00617. Fumarate ester clickable probe toolbox: gel-based ...

Another new rival is Biogen’s recently-approved Vumerity (diroximel fumarate), a follow-up to the company’s Tecfidera (dimethyl fumarate) which made $4 billion last year and is the top-selling ...

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...